Advanced Micro Devices, Inc. - Common Stock (AMD)
420.99
-3.11 (-0.73%)
NASDAQ· Last Trade: May 18th, 5:20 PM EDT
AMD's server CPU revenue could take off substantially over the next five years.
Via The Motley Fool · May 18, 2026
Advanced Micro Devices just disclosed an equity position in Marvell Technology.
Via The Motley Fool · May 18, 2026
SoundHound AI and Aurora Innovation both have to execute on turning opportunity into revenue.
Via The Motley Fool · May 18, 2026
Four of the most heavily traded AI semiconductor stocks just hit “extreme exhaustion” readings on a composite technical model that has historically preceded sharp reversals.
Via Benzinga · May 18, 2026
AMD stock slides 2% despite CEO Lisa Su striking a constructive tone in Beijing. See why Citi aggressively raised its target to $460 on a massive $131B AI server boom in 2026.
Via Benzinga · May 18, 2026
The two chipmakers just reached all-time highs, but are either still a good buy?
Via The Motley Fool · May 18, 2026
One Lane Closed. The Whole Rate Picture Changedchartmill.com
Via Chartmill · May 18, 2026
Cerebras aims to take on leader Nvidia in the AI chip market.
Via The Motley Fool · May 17, 2026
Bill.com Holdings delivers cloud-based automation solutions for financial operations, serving small and midsize businesses worldwide.
Via The Motley Fool · May 17, 2026
AMD's AI story is getting bigger, but the stock already prices in a lot. Here's what investors need to watch before investing.
Via The Motley Fool · May 17, 2026
Nvidia is well-positioned to continue shaping the future of artificial intelligence.
Via The Motley Fool · May 16, 2026
These are excellent companies, but only one can be the winner in this comparison.
Via The Motley Fool · May 16, 2026
4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m
Via MarketBeat · May 16, 2026
AMD looks poised to be a huge agentic AI winner.
Via The Motley Fool · May 16, 2026
After seeing enough demand, ARM Holdings said they, too, are getting into the semiconductor manufacturing business.
Via The Motley Fool · May 16, 2026
The chipmaker just reported a stellar quarter and rocketed to all-time highs.
Via The Motley Fool · May 16, 2026
The market loved AMD's latest quarter.
Via The Motley Fool · May 16, 2026
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
Intel may be mounting an impressive comeback, but AMD and Arm are still taking share in the AI-driven server CPU race.
Via Barchart.com · May 16, 2026
Investors may be eager to get in on this new AI growth story.
Via The Motley Fool · May 16, 2026
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported first-quarter 2026 results and used its earnings call to highlight progress across its cell therapy pipeline, including its lead OpRegen program in geographic atrophy, a newly launched corneal endothelial cell program called COR1, and ongoing ma
Via MarketBeat · May 15, 2026
What Happened? Shares of computer processor maker Intel (NASDAQ:INTC) fell 5.8% in the afternoon session after a research report confirmed the company was lo...
Via StockStory · May 15, 2026
Arm Holdings claims that it can substantially reduce the cost of deploying server CPUs in AI data centers.
Via The Motley Fool · May 15, 2026
AMD has disclosed a stake in Marvell Technologies
Via Barchart.com · May 15, 2026
Advanced Micro is surfing the AI boom. However, Daiwa Securities hints the market’s blistering rally might soon moderate its pace.
Via Barchart.com · May 15, 2026
AMD is no longer an AI infrastructure afterthought.
Via The Motley Fool · May 15, 2026